Efficacy and safety of erythropoietin in isolated spinal metastasis patients with total en bloc spondylectomy surgery: a case–control study
Efficacy and safety of erythropoietin in isolated spinal metastasis patients with total en bloc spondylectomy surgery: a case–control study
复制标题
DOI:
10.1007/s00586-023-07554-2
复制
发表时间:
2023-01
影响因子:
2.8
通讯作者:
Shuang-Sheng Cao;Kai Lv;Cheng Peng;Guangjian Bai;Xin Gao;Jing Wang;Jiashi Cao;Rende Ning;Jianjun Chu;Tielong Liu
中科院分区:
文献类型:
--
作者:
Shuang-Sheng Cao;Kai Lv;Cheng Peng;Guangjian Bai;Xin Gao;Jing Wang;Jiashi Cao;Rende Ning;Jianjun Chu;Tielong Liu
ObjectiveThe purpose of our study is to identify the effect of short-term and high-dose use of erythropoietin (EPO) in spinal isolated metastatic patients with Total en bloc spondylectomy (TES) surgery by assessing hematological parameters, transfusion volume, postoperative complications, recurrence-free survival (RFS), and overall survival (OS).MethodsFrom January 2015 and January 2022, 93 isolated spinal metastasis patients were selected and separated into 2 groups based on the treatment method used (EPO + TXA (Tranexamic acid) group,n= 47; and TXA group,n= 46). Indexes for evaluation included hemoglobin (Hb), hematocrit (Hct), red blood cells (RBC), RFS, OS, postoperative complications, postoperative Frankel Grade, drainage volume, transfusion rate, and mean units transfused.ResultsThe average follow-up duration was 38.13 months. There was no significant difference (P> 0.05) in RFS, OS, postoperative complications, postoperative Frankel Grade, drainage volume, and transfusion rate between the two groups. However, patients in EPO + TXA group have significantly higher Hb, Hct, and RBC values than those in the TXA group on postoperative days 1, 2, 3, and 5. Moreover, the mean transfusion volume in EPO + TXA group was significantly lower than those in the TXA group (P= 0.011).ConclusionsPerioperative short-term and high-dose administration of EPO could improve the anemia-related hematological parameters and reduce the requirement for blood transfusion without increasing the risk of deep vein thrombosis and tumor progression in solitary spinal metastatic patients with TES surgery.